Watch CNBC's full interview with Eli Lilly CEO David Ricks

Eli Lilly CEO David Ricks joins CNBC's Meg Tirrell and the 'Squawk Box' team to break down the company's latest earnings report and its clinical trial results for weight-loss drug tirzepatide. "We're putting a lot more things on airplanes than ships and re-routing around all the constraints we have," Ricks tells CNBC regarding how the pharma giant has maneuvered around supply chain issues.